📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ARQT.
💹 Market Data
Market Cap$2.68B
Shares Outstanding125.08M
Float92.59M
Cash$224.00M
Debt$114.67M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 2.9% shares (2025Q4 vs prior)
281 institutional holders · 131.85M shares
#1
SUVRETTA CAPITAL MANAGEMENT, LLC
11.96M shares
#2
Frazier Life Sciences Management, L.P.
9.87M shares
#3
BlackRock, Inc.
9.10M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest16.88M
Days to Cover16.6
% of Float18.2%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2020
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Mar 04, 2026
4
INSIDER TRANSACTION
Mar 04, 2026
4
INSIDER TRANSACTION
Mar 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ARQT
📊 ARQT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ARQT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.